 In 1999, by political decision of Slobodan Milošević's regime, the FR Yugoslavia took over the majority stake of the company.Following the overthrow of Slobodan Milošević in October 2000, the company returned on track and each year had tens of million euros of positive net income.As of 2006, Galenika remained a leader in research and development as the only pharmaceutical company in Serbia with an institute registered with the Ministry of Science and Environmental Protection.